Managing Issues in Dialysis for the Patient with AKI.
作者信息
Judd Eric, Tolwani Ashita
机构信息
Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
出版信息
Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1538-1542. doi: 10.2215/CJN.02270217. Epub 2017 Jun 21.
Abstract
摘要
相似文献
1
Managing Issues in Dialysis for the Patient with AKI.急性肾损伤患者透析问题的管理
Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1538-1542. doi: 10.2215/CJN.02270217. Epub 2017 Jun 21.
2
Sodium citrate anticoagulation during sustained low efficiency dialysis (SLED) in patients with acute renal failure and severely impaired liver function.急性肾衰竭合并严重肝功能损害患者在持续性低效透析（SLED）期间使用柠檬酸钠抗凝。
Nephrol Dial Transplant. 2008 Jan;23(1):421-2. doi: 10.1093/ndt/gfm629. Epub 2007 Oct 3.
3
Replacement and dialysate fluids for patients with acute renal failure treated by continuous veno-venous haemofiltration and/or haemodiafiltration.
Contrib Nephrol. 2004;144:317-28. doi: 10.1159/000078899.
4
Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.在局部枸橼酸盐抗凝情况下使用含磷酸盐置换液的持续静脉-静脉血液滤过。
Int J Artif Organs. 2013 Dec;36(12):845-52. doi: 10.5301/ijao.5000283. Epub 2013 Dec 12.
5
Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.危重症患者连续性持续低效透析（C-SLED）中局部枸橼酸盐抗凝的安全性
Ren Fail. 2005;27(5):541-5. doi: 10.1080/08860220500198748.
6
Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.肝素与枸橼酸盐作为急性肾衰竭需要肾脏替代治疗患者非隧道式中心静脉血液透析导管封管溶液的比较（VERROU-REA研究）：一项随机对照试验的研究方案
Trials. 2014 Nov 19;15:449. doi: 10.1186/1745-6215-15-449.
7
Citrate-Buffered Dialysis Solution (Citrasate) Allows Avoidance of Anticoagulation During Intermittent Hemodiafiltration-At the Cost of Decreased Performance and Systemic Biocompatibility.柠檬酸盐缓冲透析液（Citrasate）可避免间歇性血液透析滤过期间的抗凝——代价是性能下降和全身生物相容性降低。
Artif Organs. 2017 Aug;41(8):759-766. doi: 10.1111/aor.12851. Epub 2016 Nov 10.
8
Applying Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy for Acute Kidney Injury Patients with Acute Liver Dysfunction: a Retrospective Observational Study.区域枸橼酸抗凝在急性肝功能不全的急性肾损伤患者连续性肾脏替代治疗中的应用：一项回顾性观察研究
Kidney Blood Press Res. 2018;43(4):1065-1074. doi: 10.1159/000491057. Epub 2018 Jul 3.
9
Bioenergetic gain of citrate anticoagulated continuous hemodiafiltration--a comparison between 2 citrate modalities and unfractionated heparin.枸橼酸盐抗凝连续性血液透析滤过的生物能量增益——两种枸橼酸盐模式与未分馏肝素的比较。
J Crit Care. 2013 Feb;28(1):87-95. doi: 10.1016/j.jcrc.2012.06.003. Epub 2012 Aug 27.
10
A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration.两种用于连续性静脉-静脉血液滤过的枸橼酸盐抗凝方案的比较。
Int J Artif Organs. 2005 Dec;28(12):1211-8. doi: 10.1177/039139880502801203.
Zotero 插件